NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/08/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization12,430 mln
Float126 mln
Earnings Date07/30/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.68
Likely reliable
1-Year Forecast
128
Strong upside
Relative Strength
84
/ 100
Strongly outperforming
Debt / Equity
-17.22
Negative equity
Dividend Yield
0.00%
No dividend
Business Description
Guardant Health is a cancer diagnostics company founded in 2011 and based in Palo Alto, California, that develops blood and tissue tests to detect and analyze cancer. Its products help doctors identify genetic changes in tumors, guiding treatment decisions for patients, and also include a blood test designed to screen healthy adults for colorectal cancer. The company additionally supports pharmaceutical research by offering data, software tools, and services that help connect patients with relevant clinical trials and advance the development of new cancer therapies.
